一种简单的饮食和化学诱导的小鼠NASH模型,可快速进展为脂肪性肝炎、纤维化和肝癌
研究旨在建立快速进展的小鼠NASH模型,采用高脂高果糖高胆固醇的西方饮食联合每周低剂量腹腔注射四氯化碳。C57BL/6J小鼠喂养12周和24周后,联合处理组出现3期纤维化(12周)和肝细胞癌(24周),转录组和免疫特征与人NASH相似。该模型可模拟人NASH的组织学、免疫和转录组特征,作者认为可作为临床前药物测试的实验工具。
要点
- 西方饮食联合低剂量四氯化碳可在12周诱导小鼠3期纤维化,24周诱导肝细胞癌。
- 联合处理组小鼠的肝脏转录组和免疫特征与人NASH相似。
- 该模型快速且可重复,作者认为可用于研究发病机制和测试新疗法。
核心结论
- 该小鼠NASH模型表现出晚期纤维化和肝细胞癌的快速进展,并模拟人NASH的组织学、免疫学和转录组学特征,作者认为其将成为临床前药物测试的有用实验工具。
研究设计与样本
- 使用C57BL/6J小鼠,分别给予正常饲料±四氯化碳或西方饮食±四氯化碳,持续12周和24周。
- 西方饮食为高脂、高果糖和高胆固醇饮食,四氯化碳为每周低剂量腹腔注射,作为加速剂。
主要发现
- 添加四氯化碳加剧了西方饮食诱导的NASH组织学特征、纤维化和肿瘤发展,导致12周出现3期纤维化,24周出现肝细胞癌。
- 全肝转录组分析表明,西方饮食/四氯化碳小鼠中失调的分子通路和免疫特征与人NASH相似。
临床怎么用
- 作者认为该模型可作为临床前药物测试的实验工具。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Although the majority of patients with non-alcoholic fatty liver disease (NAFLD) have only steatosis without progression, a sizeable fraction develop non-alcoholic steatohepatitis (NASH), which can lead to cirrhosis and hepatocellular carcinoma (HCC). Many established diet-induced mouse models for NASH require 24-52 weeks, which makes testing for drug response costly and time consuming. METHODS: We have sought to establish a murine NASH model with rapid progression of extensive fibrosis and HCC by using a western diet (WD), which is high-fat, high-fructose and high-cholesterol, combined with low weekly dose of intraperitoneal carbon tetrachloride (CCl4), which serves as an accelerator. RESULTS: C57BL/6J mice were fed a normal chow diet ± CCl4 or WD ± CCl4 for 12 and 24 weeks. Addition of CCl4 exacerbated histological features of NASH, fibrosis, and tumor development induced by WD, which resulted in stage 3 fibrosis at 12 weeks and HCC development at 24 weeks. Furthermore, whole liver transcriptomic analysis indicated that dysregulated molecular pathways in WD/CCl4 mice and immunologic features were similar to those of human NASH. CONCLUSIONS: Our mouse NASH model exhibits rapid progression of advanced fibrosis and HCC, and mimics histological, immunological and transcriptomic features of human NASH, suggesting that it will be a useful experimental tool for preclinical drug testing. LAY SUMMARY: A carefully characterized model has been developed in mice that recapitulates the progressive stages of human fatty liver disease, from simple steatosis, to inflammation, fibrosis and cancer. The functional pathways of gene expression and immune abnormalities in this model closely resemble human disease. The ease and reproducibility of this model make it ideal to study disease pathogenesis and test new treatments.
引用
- Tsuchida T, Lee YA, Fujiwara N, et al. A simple diet- and chemical-induced murine NASH model with rapid progression of steatohepatitis, fibrosis and liver cancer. J Hepatol. 2018. PMID: 29572095. doi:10.1016/j.jhep.2018.03.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。